Sales
Drug Industry Innovation: GSK’s LOVAZA Vs. OTC Omega-3 Fatty Acid Supplements
Thursday, January 21st, 2010
The pharmaceutical industry is often criticized for developing new Rx drugs having little value over current medications. Such drugs are called “me-too” drugs because of their similarity to existing Rx drugs
Read the full story
Creative Pharma Packaging Design: Where Is It Needed?
Wednesday, January 13th, 2010
Guy Mastrion ( @gmastrion ) over at Pixels & Pills Blog took offense when a colleague “bemoaned the conservative design of most Pharma packaging” and said it was “inevitable since Pharma was a ‘Creative Ghetto.’” See ” Breaking Out of the Creative Ghetto .” Now, you know, whenever someone mentions creativity and pharma or pharma marketing in the same sentence, I get out my blogging pistol. When ads like those for Rozerem win awards for creativity but do not help ROI, I am especially annoyed (see ” Rozerem Ads Dis Lincoln, Show Beaver “, ” MM&M Award Winners Announced at Gala NY Event! “, and ” Another Award for Rozerem! This one…not so good
Read the full story
Long Term Care Marketing: How Care is Delivered is Key
Tuesday, June 30th, 2009
If you market or sell to the long-term care segment or if you’re considering this, be advised: Adopting strategies and messaging similar to those you use for the acute care or physician practice setting won’t work.
Read the full story
Measuring the Value of KOL Interactions
Tuesday, June 23rd, 2009
Thought leaders are a critical component of a pharmaceutical company?s professional marketing and medical strategies. But companies face a real challenge in creating, maintaining, and leveraging those relationships while safely navigating logistical issues and regulatory waters.
Read the full story
Paying physicians for their time or hearts?
Thursday, June 18th, 2009
At what point in time do you trade you principles for gold? Dr Timothy R.
Posted in: Sales | 0 Comments »
Read the full story
Shared Detail Appointments Can Save Doctors’ Time & Improve Product Education
Sunday, June 14th, 2009
In the recent issue of the AARP Bulletin, I read about doctors scheduling appointments with up to 15 patients at the same time (see ” Doctors Take Sharing to a New Level”Medical Appointments “). It’s called a “Shared Medical Appointment.” “SMAs allow as many as 15 patients to schedule an appointment with one doctor for a 90-minute session. The physician interacts with individual patients as needed, but usually addresses questions with the entire group.” I’m sure the typical SMA session does not last 90 minutes
Posted in: Sales | 0 Comments »
Read the full story
Business Week – Drug Marketing
Business Week – Pharma Marketing
Cafe Pharma
Clinical Trials.gov
FDA on Twitter
Pharma Live
Pharma Voice